NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
69.96
+1.31 (+1.91%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close68.65
Open68.60
Bid49.00 x 800
Ask199,999.98 x 800
Day's Range67.97 - 70.02
52 Week Range44.62 - 70.02
Volume584,628
Avg. Volume611,323
Market Cap3.598B
Beta0.63
PE Ratio (TTM)84.29
EPS (TTM)0.83
Earnings DateOct 22, 2018 - Oct 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est61.80
Trade prices are not sourced from all markets
  • NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility
    PR Newswire4 days ago

    NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility

    SAN DIEGO, Aug. 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Dale Wolf as vice president, Manufacturing, who will oversee the Company's West Carrollton, Ohio manufacturing facility. Mr. Wolf will fill a newly created role emphasizing the importance of the company's goal to become a world-class manufacturer.

  • PR Newswire11 days ago

    NuVasive and Siemens Healthineers partner to transform spine surgery

    SAN DIEGO and ERLANGEN, Germany, Aug. 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA) and Siemens Healthineers today announced a strategic partnership focused on technology development, marketing and commercial activities to advance clinical outcomes in minimally invasive spine surgery. NuVasive is an innovation leader in spine health technology, focused on transforming spine surgery with minimally disruptive, predictable and clinically reproducible procedurally-integrated solutions, while Siemens Healthineers offers surgeons a broad portfolio of imaging systems including 3D imaging for complex spine cases. In their Spine Precision Partnership™, the companies will join forces in advancing their proprietary technologies with the objective of creating solutions which improve operating room (OR) workflow efficiency and provide increased precision in the delivery of minimally disruptive spine surgery technologies.

  • See what the IHS Markit Score report has to say about NuVasive Inc.
    Markit11 days ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    NuVasive Inc NASDAQ/NGS:NUVA

  • Why This Healthcare Innovator Sees a Brighter Future
    Motley Fool17 days ago

    Why This Healthcare Innovator Sees a Brighter Future

    NuVasive is going through some growing pains, but the spinal surgical equipment maker has high hopes.

  • See what the IHS Markit Score report has to say about NuVasive Inc.
    Markit18 days ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • Why NuVasive, Inc. Stock Jumped Today
    Motley Fool19 days ago

    Why NuVasive, Inc. Stock Jumped Today

    Investors cheered, as short-term pain in the first half of 2018 for NuVasive could lead to a stronger performance in the future.

  • NuVasive (NUVA) Q2 Earnings Meet Estimates, EPS View Down
    Zacks19 days ago

    NuVasive (NUVA) Q2 Earnings Meet Estimates, EPS View Down

    NuVasive (NUVA) expects robust demand for recently-launched products and positive surgeon conversion efforts as its new Lateral Single-Position Surgery procedure gains traction in the market.

  • Thomson Reuters StreetEvents19 days ago

    Edited Transcript of NUVA earnings conference call or presentation 31-Jul-18 8:30pm GMT

    Q2 2018 NuVasive Inc Earnings Call

  • NuVasive (NUVA) Q2 Earnings Match Estimates
    Zacks20 days ago

    NuVasive (NUVA) Q2 Earnings Match Estimates

    NuVasive (NUVA) delivered earnings and revenue surprises of 0.00% and 2.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press20 days ago

    NuVasive: 2Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had profit of 22 cents. Earnings, adjusted for one-time gains and costs, were 58 cents per share. The results met Wall Street expectations. The ...

  • NuVasive Announces Second Quarter 2018 Financial Results
    PR Newswire20 days ago

    NuVasive Announces Second Quarter 2018 Financial Results

    SAN DIEGO , July 31, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated ...

  • ACCESSWIRE20 days ago

    NuVasive, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 31, 2018 / NuVasive, Inc. (NASDAQ: NUVA ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 31, 2018 at 4:30 PM Eastern Time. To listen ...

  • NuVasive (NUVA) in Focus: Stock Moves 6.02% Higher
    Zacks20 days ago

    NuVasive (NUVA) in Focus: Stock Moves 6.02% Higher

    NuVasive (NUVA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

  • ACCESSWIRE20 days ago

    Today's Research Reports on Trending Tickers: Tandem Diabetes Care and NuVasive

    NEW YORK, NY / ACCESSWIRE / July 31, 2018 / U.S. markets continued to drop on Monday, as tech sector close in the red weighed by majority of the FAANG (Facebook, Apple, Amazon, Netflix and Google parent ...

  • Medical Product Stock Earnings on Jul 31: HOLX, NUVA, QSII
    Zacks21 days ago

    Medical Product Stock Earnings on Jul 31: HOLX, NUVA, QSII

    Let's take a look at the factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.

  • NuVasive Unveils Spine's First Integrated Surgical Automation Platform
    PR Newswire24 days ago

    NuVasive Unveils Spine's First Integrated Surgical Automation Platform

    Pulse™ platform receives 510(k) clearance addressing spine technology and clinical requirements across all spine procedures SAN DIEGO , July 27, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...

  • Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment
    PR Newswirelast month

    Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment

    SAN DIEGO, July 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. launch of MAGEC X, a new procedural solution within the MAGEC product family that addresses Early Onset Scoliosis (EOS). When paired with the NuVasive Reline® Small Stature system, the first pediatric deformity fixation solution to integrate both 4.5mm and 5.0mm rods in a low-profile tulip, MAGEC X provides increased construct strength without sacrificing the optimal profile for EOS patients. "NuVasive's MAGEC X 5.0mm solution is unique because it allows you to upsize your rod with low-profile screws, giving you the flexibility at the time of surgery to use a larger rod without having to change your screws – that's really key," said Dr. Peter Sturm, Alvin H. Crawford Chair of Spine Surgery, Cincinnati Children's Hospital Medical Center.

  • ACCESSWIRElast month

    Free Pre-Market Technical Recap on Nevro and Three Additional Medical Equipment Stocks

    On Friday, July 13, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Friday's trading session in bullish territories. Taking into consideration last Friday's market sentiment, WallStEquities.com assessed the following Medical Appliances & Equipment equities this morning: Nevro Corp. (NYSE: NVRO), NovoCure Ltd (NASDAQ: NVCR), NuVasive Inc. (NASDAQ: NUVA), and Stryker Corp. (NYSE: SYK).

  • NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation
    PR Newswirelast month

    NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation

    RMM incorporates extremely low-profile modular implants and advanced system instrumentation to address alignment and potentially reduce adjacent segment transition syndrome. The system, when combined with NuVasive access and interbody technologies, is designed to provide a minimally invasive approach to bilateral decompression under complete visualization, interbody fusion and stabilization with pedicle screws. Furthermore, RMM tulip pull-off strength is comparable to preassembled pedicle screws.

  • NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results
    PR Newswirelast month

    NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results

    SAN DIEGO, July 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its second quarter 2018 earnings results on Tuesday, July 31, 2018 after the close of the market. NuVasive will hold a conference call on Tuesday, July 31, 2018 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the second quarter 2018. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.

  • NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018
    PR Newswirelast month

    NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018

    XLX™ ACR® receives FDA 510(k) clearance and broadens expandable portfolio to include lateral procedures SAN DIEGO , July 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology ...

  • Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions
    PR Newswirelast month

    Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions

    SAN DIEGO, July 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the first peer-reviewed publication from the NuVasive-sponsored multicenter Integrated Global Alignment (iGA®) study is now available in the journal Spine. This initial study evaluated the preoperative prevalence and incidence of postoperative spinopelvic malalignment in patients who underwent one- or two-level lumbar fusions for degenerative (non-deformity) indications. The article, "A multicenter radiographic evaluation of the rates of preoperative and postoperative malalignment in degenerative spinal fusions," reports on the rates of malalignment in nearly 600 patients whose measurements were retrospectively acquired.

  • GlobeNewswire2 months ago

    Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of NuVasive, Inc. -- NUVA

    SAN DIEGO, July 02, 2018-- Pomerantz LLP announces that the United States District Court Southern District of California has approved the following announcement of a proposed class action settlement that ...

  • Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day
    Zacks2 months ago

    Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day

    Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day

  • 3 Stocks to Tap the Minimally-Invasive Surgery Market Boom
    InvestorPlace2 months ago

    3 Stocks to Tap the Minimally-Invasive Surgery Market Boom

    The United States has hit rough waters of late. Rising trade war tensions between the United States and China are showing no signs of abatement. The issue has escalated to a point where imposition of tariffs and retaliatory tariffs may go up to $450 billion on both the sides.